Issues - Dicembre 2024

Mosher CE, Lee S, Addington EL, et al.

Randomized controlled trial of acceptance and commitment therapy for fatigue interference with functioning in metastatic breast cancer

J Clin Oncol 2024 Oct 25:JCO2400965. Epub ahead of print

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract | Scarica ppt

---

Oliveira M, Pominchuk D, Nowecki Z, et al.

Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial

Lancet Oncol 2024;25(11):1424-1439

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract | Scarica ppt

---

Montagna G, Laws A, Ferrucci M, et al.

Nodal burden and oncologic outcomes in patients with residual isolated tumor cells after neoadjuvant chemotherapy (ypN0i+): the OPBC-05/ICARO study

J Clin Oncol 2024 Nov 7:JCO2401052. Epub ahead of print

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract | Scarica ppt

---

Turner NC, Im SA, Saura C, et al.

Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer

N Engl J Med 2024;391(17):1584-1596

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract | Scarica ppt

---

Romanos-Nanclares A, Willett WC, Rosner B, et al.

Proinflammatory dietary pattern and risk of total and subtypes of breast cancer among U.S. women

J Natl Cancer Inst 2024 Nov 20:djae301. Epub ahead of print

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract | Scarica ppt

---

Huppert LA, Wolf D, Yau C, et al.

Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial

Ann Oncol 2024 Oct 28:S0923-7534(24)04070-5. Epub ahead of print

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

de Azambuja E, Piccart-Gebhart M, et al.

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]

ESMO Open 2024;9(11):103938

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

Molinelli C, Bruzzone M, Blondeaux E, et al.

The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: a real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study

Eur J Cancer 2024 Nov 4;213:115113. Epub ahead of print

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

Johnson HM, Song J, Warneke CL, et al.

Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy

Cancer 2024 Oct 29. Epub ahead of print

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

Brufsky A, Kwan ML, Sandin R, et al.

Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2- and HER2+ metastatic breast cancer

Breast Cancer Res Treat 2024;208(2):223-235

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

Zhang Q, Freeman JQ, Zhao F, et al.

Clinical Outcomes and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Breast Cancer With Uncommon In Situ Hybridization Patterns or Discordant Immunohistochemistry

J Clin Oncol Advances 2024:1

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

van ‘t Veer LJ, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, et al.

Selection of patients with early-stage breast cancer for extended endocrine therapy: a secondary analysis of the IDEAL randomized clinical trial

JAMA Netw Open 2024;7(11):e2447530

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

Melink Z, Lustberg MB, Schnell PM, et al.

Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial

Breast Cancer Res Treat 2024;208(3):605-617

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

Awan AA, Stober C, Pond GR, et al.

A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer

Breast Cancer Res Treat 2024;208(3):523-533

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---